Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy

Enrolling by invitationOBSERVATIONAL
Enrollment

433

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

December 30, 2024

Study Completion Date

February 25, 2025

Conditions
Non-Viable Pregnancy
Interventions
DIAGNOSTIC_TEST

Blood samples collection for analysis

"Blood samples:~Blood samples will be collected for the determination of the levels of various biomarkers (Kisspeptins and miRNAs), which are molecules that regulate the expression of proteins and can serve as markers for predicting pregnancy viability. Additionally, after biochemical or week 10 of clinical pregnancy confirmation, blood samples will be collected for KIR and HLA-C typing, Oral glucose tolerance test (OGTT) and analysis of the levels of miRNAs related with insulin resistance, miR-424-5p and miR-15b.~Uterine biopsy (only in patients with BP):~Uterine biopsy samples will be collected also after biochemical pregnancy confirmation for the determination of the levels of miRNAs related with insulin resistance, miR-424-5p and miR-15b."

Trial Locations (2)

28023

IVI RMA Madrid, Madrid

41011

IVI RMA Seville, Seville

All Listed Sponsors
collaborator

IVI Madrid

OTHER

collaborator

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

collaborator

IVI Barcelona

OTHER

lead

Vida Recoletas Sevilla

OTHER